Answers are grounded in this paper and cite their sources.
To the Editor, We read with interest the recent Infectious Diseases Society of America (IDSA)-led multisociety position paper on hospital sepsis strategies [1] and would like to raise a question about the recommendations of antibiotic-timing.In 2018, the IDSA declined to endorse the Surviving Sepsis Campaign (SSC) guideline, citing concerns that rigid, fixed time-from-recognition antibiotic targets would drive overuse of broad-spectrum agents among patients with noninfectious sepsis-mimicking syndromes "in the rush to meet the fixed frame" [2] , together with ambiguity in defining "time zero" for quality measurement.Analyses of Centers for Medicare and Medicaid Services (CMS) SEP-1 implementation subsequently documented increased hospital-wide broad-spectrum antibiotic use, although the measure's stewards disputed the interpretation of these findings [3,4] .
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: